CONTEXT: ATM is critical in response to ionizing radiation-induced DNA damage. OBJECTIVE: Variations in ATM are hypothesized to affect individual susceptibility to thyroid cancer. Our objective was to evaluate the association between ATM polymorphisms and thyroid cancer risk. DESIGN, PARTICIPANTS, AND METHODS: Six ATM single nucleotide polymorphisms (SNP) were genotyped in two independent case-control series including 592 patients with differentiated thyroid carcinoma (DTC) and 885 healthy individuals. An unconditional logistic regression model was applied to calculate odds ratios (OR) and 95% confidence intervals (CI) for each SNP with respect to risk of DTC and the combination effect of SNP on cancer risk. RESULTS: The risk-allele frequencies of all the SNP were similar in the two case-control populations. Under a dominant model of inheritance, the G allele of ATM rs189037 exhibited a protective effect against DTC (adjusted OR = 0.8; 95% CI, 0.6-1.0; P = 0.04), and the G allele of rs1800057 was associated with increased risk of DTC (adjusted OR = 1.9; 95% CI, 1.1-3.1; P = 0.02). A protective haplotype (A-G-C-T-C-A) was associated with decreased risk of DTC in non-Hispanic whites (adjusted OR = 0.2; 95% CI, 0.0-0.8; P = 0.03). A significant dose-response relationship was observed between the total number of risk alleles of ATM and DTC risk (P = 0.01). Carriers of a combination of six to seven and eight to 10 risk alleles were at 30% (adjusted OR = 1.3; 95% CI, 1.0-1.7) and 50% (adjusted OR = 1.5; 95% CI, 1.1-2.1) increased risk of DTC, respectively. CONCLUSION: Individual susceptibility to DTC may be attributable to polymorphisms of ATM, and the associations warrant confirmation in independent studies.
CONTEXT: ATM is critical in response to ionizing radiation-induced DNA damage. OBJECTIVE: Variations in ATM are hypothesized to affect individual susceptibility to thyroid cancer. Our objective was to evaluate the association between ATM polymorphisms and thyroid cancer risk. DESIGN, PARTICIPANTS, AND METHODS: Six ATM single nucleotide polymorphisms (SNP) were genotyped in two independent case-control series including 592 patients with differentiated thyroid carcinoma (DTC) and 885 healthy individuals. An unconditional logistic regression model was applied to calculate odds ratios (OR) and 95% confidence intervals (CI) for each SNP with respect to risk of DTC and the combination effect of SNP on cancer risk. RESULTS: The risk-allele frequencies of all the SNP were similar in the two case-control populations. Under a dominant model of inheritance, the G allele of ATMrs189037 exhibited a protective effect against DTC (adjusted OR = 0.8; 95% CI, 0.6-1.0; P = 0.04), and the G allele of rs1800057 was associated with increased risk of DTC (adjusted OR = 1.9; 95% CI, 1.1-3.1; P = 0.02). A protective haplotype (A-G-C-T-C-A) was associated with decreased risk of DTC in non-Hispanic whites (adjusted OR = 0.2; 95% CI, 0.0-0.8; P = 0.03). A significant dose-response relationship was observed between the total number of risk alleles of ATM and DTC risk (P = 0.01). Carriers of a combination of six to seven and eight to 10 risk alleles were at 30% (adjusted OR = 1.3; 95% CI, 1.0-1.7) and 50% (adjusted OR = 1.5; 95% CI, 1.1-2.1) increased risk of DTC, respectively. CONCLUSION: Individual susceptibility to DTC may be attributable to polymorphisms of ATM, and the associations warrant confirmation in independent studies.
Authors: Yun-Ling Zheng; Ourania Kosti; Christopher A Loffredo; Elise Bowman; Leah Mechanic; Donna Perlmutter; Raymond Jones; Peter G Shields; Curtis C Harris Journal: Int J Cancer Date: 2010-05-01 Impact factor: 7.396
Authors: Trevor J Pugh; Mira Keyes; Lorena Barclay; Allen Delaney; Martin Krzywinski; Dallas Thomas; Karen Novik; Cindy Yang; Alexander Agranovich; Michael McKenzie; W Jim Morris; Peggy L Olive; Marco A Marra; Richard A Moore Journal: Clin Cancer Res Date: 2009-07-28 Impact factor: 12.531
Authors: Olivia Fletcher; Nichola Johnson; Isabel dos Santos Silva; Nick Orr; Alan Ashworth; Heli Nevanlinna; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Barbara Burwinkel; Claus R Bartram; Alfons Meindl; Rita K Schmutzler; Angela Cox; Ian Brock; Graeme Elliott; Malcolm W R Reed; Melissa C Southey; Letitia Smith; Amanda B Spurdle; John L Hopper; Fergus J Couch; Janet E Olson; Xianshu Wang; Zachary Fredericksen; Peter Schürmann; Regina Waltes; Michael Bremer; Thilo Dörk; Peter Devilee; Christie J van Asperen; Rob A E M Tollenaar; Caroline Seynaeve; Per Hall; Kamila Czene; Keith Humphreys; Jianjun Liu; Shahana Ahmed; Alison M Dunning; Melanie Maranian; Paul D P Pharoah; Georgia Chenevix-Trench; Jonathan Beesley; Natalia V Bogdanova; Natalia N Antonenkova; Iosif V Zalutsky; Hoda Anton-Culver; Argyrios Ziogas; Hiltrud Brauch; Yon-Dschun Ko; Ute Hamann; Peter A Fasching; Reiner Strick; Arif B Ekici; Matthias W Beckmann; Graham G Giles; Gianluca Severi; Laura Baglietto; Dallas R English; Roger L Milne; Javier Benítez; José Ignacio Arias; Guillermo Pita; Børge G Nordestgaard; Stig E Bojesen; Henrik Flyger; Daehee Kang; Keun-Young Yoo; Dong Young Noh; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Montserrat García-Closas; Stephen Chanock; Jolanta Lissowska; Louise A Brinton; Jenny Chang-Claude; Shan Wang-Gohrke; Annegien Broeks; Marjanka K Schmidt; Flora E van Leeuwen; Laura J Van't Veer; Sara Margolin; Annika Lindblom; Manjeet K Humphreys; Jonathan Morrison; Radka Platte; Douglas F Easton; Julian Peto Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-09 Impact factor: 4.254
Authors: Marjory Alana Marcello; Antonio Ramos Calixto; Jacqueline Fatima Martins de Almeida; Mariana Bonjiorno Martins; Lucas Leite Cunha; Camila Ayume Amano Cavalari; Elba C S Etchebehere; Ligia Vera Montalli da Assumpção; Bruno Geloneze; Andre Lopes Carvalho; Laura Sterian Ward Journal: Int J Endocrinol Date: 2015-02-25 Impact factor: 3.257